1. Home
  2. ARAY vs BCTX Comparison

ARAY vs BCTX Comparison

Compare ARAY & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.30

Market Cap

31.3M

Sector

Health Care

ML Signal

HOLD

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.18

Market Cap

36.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARAY
BCTX
Founded
1990
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
36.6M
IPO Year
2006
2025

Fundamental Metrics

Financial Performance
Metric
ARAY
BCTX
Price
$0.30
$4.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 11.5M
149.6K
Earning Date
11-04-2026
10-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 87.50
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.75
N/A
Revenue Next Year
$2.35
$380.95
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$2.60
52 Week High
$2.10
$14.68

Technical Indicators

Market Signals
Indicator
ARAY
BCTX
Relative Strength Index (RSI) 61.57 56.58
Support Level $0.24 $4.10
Resistance Level $0.34 $4.49
Average True Range (ATR) 0.03 0.30
MACD 0.01 0.01
Stochastic Oscillator 52.97 70.00

Price Performance

Historical Comparison
ARAY
BCTX

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: